BioNTech SE (BNTX) vs Hologic, Inc. (HOLX)
HOLX leads on 6 of 10 compared metrics.
A side-by-side comparison of BioNTech SE and Hologic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BNTX vs HOLX
growth of $100 · last 6yBNTX +529.4%HOLX +56.3%BNTX compounded faster
BNTX HOLX
BNTX vs HOLX: by the numbers
- •BNTX is the larger company ($22.90B vs $16.97B market cap).
- •HOLX is profitable (13.18% net margin) while BNTX runs a net loss (-44.73%).
- •BNTX grew revenue faster over the past five years (2.16% vs -1.87% CAGR).
Which is better, BNTX or HOLX?
Metric tally: BNTX 4 · HOLX 6It depends on what you're optimizing for:
GrowthBNTX(faster 5Y revenue CAGR)
QualityHOLX(higher ROIC)
Metrics side by side
Valuation
| Metric | BNTX | HOLX |
|---|---|---|
| P/E ratio | — | 31.67 |
| Forward P/E | — | 17.21 |
| P/S ratio | 6.97 | 4.16● |
| P/B ratio | 1.06● | 3.27 |
| EV / EBITDA | — | 17.28 |
| FCF yield | 6.53%● | 5.82% |
Profitability
| Metric | BNTX | HOLX |
|---|---|---|
| Gross margin | 73.26%● | 52.82% |
| Operating margin | -51.55% | 17.49%● |
| Net margin | -44.73% | 13.18%● |
| ROE | -6.79% | 10.37%● |
| ROIC | -3.14% | 7.35%● |
Growth (annualized)
| Metric | BNTX | HOLX |
|---|---|---|
| Revenue CAGR (5Y) | 2.16%● | -1.87% |
| EPS CAGR (5Y) | — | -0.96% |
| FCF CAGR (5Y) | — | -4.57% |
| Total return CAGR (5Y) | -17.39% | 0.84%● |
Frequently asked
- Which is better, BNTX or HOLX?
- It depends on your goal. growth: BNTX (faster 5Y revenue CAGR); quality: HOLX (higher ROIC). Across all compared metrics, HOLX leads 6 to 4.
- Which has grown faster, BNTX or HOLX?
- Over the past five years, BNTX grew revenue faster — BNTX at a 2.16% CAGR versus HOLX at -1.87%.
- Is BNTX or HOLX more profitable?
- HOLX runs the higher net margin — BNTX at -44.73% versus HOLX at 13.18%.
- Which has been the better investment, BNTX or HOLX?
- Over the past 5-year, HOLX delivered the higher annualized total return — BNTX at -17.39% versus HOLX at 7.99%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioNTech SE P/E ratioHologic P/E ratioBioNTech SE dividend yieldHologic dividend yieldBioNTech SE ROEHologic ROEBioNTech SE operating marginHologic operating marginBioNTech SE revenue growthHologic revenue growthBioNTech SE free cash flowHologic free cash flow
BioNTech SE & Hologic appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.